在神经元α4β2尼古丁受体的两个静态度上,几个激动剂之间的结合变化,α4β2尼古丁受体
Ximena Da Silva Tavares1, Angela P Blum, Darren T Nakamura
1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Journal of the American Chemical Society
|June 22, 2012
概括
包括尼古丁和戒烟药物在内的四种激动剂被研究了它们与尼古丁性乙胆受体 (nAChR) 的结合相互作用. 结合的变化解释了药物的疗效和受体静脉测量选择性.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- α4β2尼古丁性乙胆受体 (nAChR) 是各种激动剂的关键标,包括乙胆 (ACh),尼古丁,瓦伦尼克林和细胞因子.
- 了解药物受体结合相互作用对于开发有效的治疗方法至关重要,特别是在戒烟方面.
- 之前的研究利用非自然的氨基酸突变发生来确定nAChR中的关键结合点.
研究的目的:
- 研究四种激动剂 (ACh,尼古丁,瓦伦尼克林,细胞因子) 的结合相互作用,在不同的固态度 (2:3和 3:2) 的α4β2 nAChR.
- 阐明子-π和结相互作用在药物结合中的作用.
- 为了合理化观察到的静脉测量选择性细胞因素.
主要方法:
- 不自然的氨基酸突变发生被用来探测nAChR的特定结合相互作用.
- ACh,尼古丁,瓦雷尼克林和细胞因素的结合在α4β2 nAChR的2:3和3:2固态度测量中进行了评估.
- 分析的重点是子-π相互作用和与受体的蛋白质骨干的结模式.
主要成果:
- 所有四种测试的激动剂都与nAChR.nAChR的TrpB形成了阴离子-π相互作用.
- 大多数激动剂与脊柱碳基形成键,其中ACH和尼古丁作为键受体.
- 瓦伦尼克林不作为键接受器与脊柱NH,而细胞素表现出独特的键,解释了其固体测量选择性.
结论:
- 这项研究揭示了ACh,尼古丁,瓦雷尼克林和细胞因子在α4β2nAChR的独特结合相互作用概况.
- 结合模式显著影响这些化合物的疗效和选择性.
- 这些发现为了解药物作用和指导新型nAChR向药物的设计提供了分子基础.
相关概念视频
Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...


